Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes

Leukemia. 2017 May;31(5):1226-1229. doi: 10.1038/leu.2017.28. Epub 2017 Jan 20.

Authors

L Guidugli¹, A K Johnson¹, G Alkorta-Aranburu¹, V Nelakuditi¹, K Arndt¹, J E Churpek², L A Godley², D Townsley³, N S Young³, C Fitzpatrick⁴, D Del Gaudio¹, S Das¹, Z Li¹

Affiliations

¹ Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
² Department of Medicine, Comprehensive Cancer Center and Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
³ Hematology Branch, Cell Biology Section, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
⁴ Department of Pathology, The University of Chicago, Chicago, IL, USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Genetic Predisposition to Disease*
Genetic Testing
Humans
Infant
Leukemia / genetics*
Male
Middle Aged
Myelodysplastic Syndromes / genetics*
Young Adult